JUBLPHARMA.NS
Price:
$1054.5
Market Cap:
$167.14B
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-07-01
Stock Exchange
NSE
Ticker
JUBLPHARMA.NS
According to Jubilant Pharmova Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 189.73B. This represents a change of 4.95% compared to the average of 180.79B of the last 4 quarters.
The mean historical Enterprise Value of Jubilant Pharmova Limited over the last ten years is 127.97B. The current 189.73B Enterprise Value has changed 14.73% with respect to the historical average. Over the past ten years (40 quarters), JUBLPHARMA.NS's Enterprise Value was at its highest in in the September 2024 quarter at 203.17B. The Enterprise Value was at its lowest in in the June 2016 quarter at 53.48B.
Average
127.97B
Median
130.59B
Minimum
71.01B
Maximum
181.21B
Discovering the peaks and valleys of Jubilant Pharmova Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 104.90%
Maximum Annual Enterprise Value = 181.21B
Minimum Annual Increase = -53.69%
Minimum Annual Enterprise Value = 71.01B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 162.07B | 37.05% |
| 2024 | 118.26B | 66.54% |
| 2023 | 71.01B | -15.38% |
| 2022 | 83.91B | -53.69% |
| 2021 | 181.21B | 104.90% |
| 2020 | 88.44B | -38.12% |
| 2019 | 142.93B | -13.02% |
| 2018 | 164.32B | 2.27% |
| 2017 | 160.67B | 50.32% |
| 2016 | 106.89B | 56.38% |
The current Enterprise Value of Jubilant Pharmova Limited (JUBLPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
117.11B
5-year avg
123.29B
10-year avg
127.97B
Jubilant Pharmova Limited’s Enterprise Value is greater than Alembic Pharmaceuticals Limited (180.19B), greater than Alembic Pharmaceuticals Limited (180.19B), greater than Caplin Point Laboratories Limited (138.58B), less than Eris Lifesciences Limited (234.75B), less than Eris Lifesciences Limited (234.75B), greater than NATCO Pharma Limited (165.43B), greater than NATCO Pharma Limited (165.43B), greater than Granules India Limited (153.18B), greater than Granules India Limited (153.18B), greater than Poly Medicure Limited (184.25B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 180.19B | $166.86B | |
| 180.19B | $166.73B | |
| 138.58B | $145.00B | |
| 234.75B | $211.57B | |
| 234.75B | $211.42B | |
| 165.43B | $163.86B | |
| 165.43B | $163.63B | |
| 153.18B | $141.20B | |
| 153.18B | $140.84B | |
| 184.25B | $181.95B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jubilant Pharmova Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jubilant Pharmova Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Jubilant Pharmova Limited's Enterprise Value?
What is the highest Enterprise Value for Jubilant Pharmova Limited (JUBLPHARMA.NS)?
What is the 3-year average Enterprise Value for Jubilant Pharmova Limited (JUBLPHARMA.NS)?
What is the 5-year average Enterprise Value for Jubilant Pharmova Limited (JUBLPHARMA.NS)?
How does the current Enterprise Value for Jubilant Pharmova Limited (JUBLPHARMA.NS) compare to its historical average?